ARQT Arcutis Biotherapeutics, Inc.

NEUTRAL Impact: 3/10 PRESS-RELEASE
Horizon days Filed Apr 15, 2026 Processed 1mo ago Wire GlobeNewswire
Press release: earnings
Latest settled — T+20d
ARQT ▼ -10.33% at T+20d
NEUTRAL call ✗ call lost -10.33% · α vs SPY -16.15% · entry $24.19 → $21.69
Next anchor: T+60d in 27d
Currently $24.38 · +0.79% from $24.19 entry
Entry anchored
Apr 15, 03:59 PM ET
via Databento tick
T+1d
+1.41%
call +1.41% · α +0.19%
$24.53
settled 8w ago
T+5d
-5.50%
call -5.50% · α -6.48%
$22.86
settled 7w ago
T+20d
-10.33%
call -10.33% · α -16.15%
$21.69
settled 4w ago
T+60d
call — · α —
in 27d

Price Chart

Loading chart...

Executive Summary

Arcutis Biotherapeutics (ARQT) announced it will report Q1 2026 financial results on May 6, 2026, after market close. The press release contains no actual financial results for Q1 2026 but references a prior earnings beat in Q4 2025 where EPS was $0.13 vs. consensus of $-0.04, a 454.5% beat.

Actionable Insight

Traders should prepare for Q1 2026 earnings release on May 6, 2026. The prior quarter's strong beat may raise expectations, but no guidance for current quarter is provided. Monitor for updates on product performance and revenue trends during the call.

Key Facts

  • Company to report Q1 2026 financial results on May 6, 2026
  • No actual Q1 2026 financials disclosed in this release
  • Reference to Q4 2025 EPS of $0.13 (consensus: $-0.04), a 454.5% beat
  • Conference call scheduled for May 6, 2026 at 4:30pm ET

Financial Impact

No immediate financial impact from this announcement — forward-looking only

revenueeps

Risk Factors

  • Forward-looking statements subject to risks in business, reimbursement, and competition
  • No confirmation of revenue or earnings trends for Q1 2026

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3274854
8 reports for ARQT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ARQT — sortable, filterable
Type Now
Jun 9, 2026
3d ago
8-K
NEUTRAL ★ 2/10
$22.78 awaiting T+5awaiting T+5$24.38 (+7.02%)
May 11, 2026
4w ago
144
NEUTRAL ★ 1/10
$20.69 $20.03▼ −3.19%▼ −3.27%$24.38 (+17.83%)
May 6, 2026
5w ago
Press Release
MIXED ★ 5/10
$20.66 $21.69▲ +4.99%▲ +3.48%$24.38 (+18.01%)
May 4, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$23.49 $21.24▼ −9.58%▼ −12.51%$24.38 (+3.79%)
May 1, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$23.35 $20.66▼ −11.52%▼ −13.87%$24.38 (+4.41%)
Apr 15, 2026
8w ago
Press Release
NEUTRAL ★ 3/10
$24.19 $22.86▼ −5.50%▼ −6.48%$24.38 (+0.79%)
Mar 2, 2026
14w ago
Insider Cluster
BEARISH ★ 6/10
$24.76 $24.82▼ −0.24%▼ −1.45%$24.38 (+1.53%)
Mar 2, 2026
14w ago
Insider Cluster
NEUTRAL ★ 4/10
$24.76 $24.82▲ +0.24%▲ +1.45%$24.38 (−1.53%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (48h 47m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access